Shanghai Bovax Biotechnology Co., Ltd.

This study tests a new 15-valent HPV vaccine to see if it is safe and triggers a strong immune response. It involves 330 healthy Chinese volunteers aged 9 to 45. Participants receive three doses of the vaccine or a placebo, and researchers monitor side effects and antibody levels…